{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:41:11Z","timestamp":1782603671822,"version":"3.54.5"},"reference-count":25,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Key Program of Science and Technology Agency, Sichuan Province","award":["No. 2017JY0067"],"award-info":[{"award-number":["No. 2017JY0067"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2020,2,13]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the safety of ceftriaxone in paediatric patients and systematically evaluate the categories and incidences of adverse drug reactions (ADRs) of ceftriaxone in paediatric patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a systematic search in Medline, PubMed, Cochrane Central Register of Controlled Trials, EMBASE, CINAHL, International Pharmaceutical Abstracts and bibliographies of relevant articles up to December 2018 for all types of studies that assessed the safety of ceftriaxone in paediatric patients aged \u226418 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>112 studies met the inclusion criteria involving 5717 paediatric patients who received ceftriaxone and reported 1136 ADRs. The most frequent ADRs reported in prospective studies were gastrointestinal (GI) disorders (37.4 %, 292\/780), followed by hepatobiliary disorders (24.6%, 192\/780). Serious ADRs leading to withdrawal or discontinuation of ceftriaxone were reported in 86 paediatric patients. Immune haemolytic anaemia (34.9%, 30\/86) and biliary pseudolithiasis (26.7%, 23\/86) were the two major causes. Haemolytic anaemia following intravenous ceftriaxone led to death in 11 children whose primary disease was sickle cell disease. Almost all biliary pseudolithiasis are reversible. However, the incidence was high affecting one in five paediatric patients (20.7%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>GI ADRs are the most common toxicity of ceftriaxone in paediatric patients. Immune haemolytic anaemia and biliary pseudolithiasis are the most serious ADRs and the major reasons for discontinuation of ceftriaxone. Immune haemolytic anaemia is more likely in children with sickle cell disease and may cause death. Ceftriaxone should be used with caution in children with sickle cell disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>CRD42017055428<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2019-317950","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T13:50:19Z","timestamp":1600437019000},"page":"981-985","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Safety of ceftriaxone in paediatrics: a systematic review"],"prefix":"10.1136","volume":"105","author":[{"given":"Linan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3069-6323","authenticated-orcid":false,"given":"Imti","family":"Choonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"2024092103001041000_105.10.981.1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039050-00003"},{"key":"2024092103001041000_105.10.981.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001183220301"},{"key":"2024092103001041000_105.10.981.3","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262070-00005"},{"key":"2024092103001041000_105.10.981.4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2147\/PPA.S140002","article-title":"Antibiotic use for pneumonia among children under-five at a pediatric hospital in Dhaka City, Bangladesh","volume":"11","author":"Rashid","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"2024092103001041000_105.10.981.5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2710.2011.01321.x","article-title":"Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian pharmacovigilance centre","volume":"37","author":"Shalviri","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"2024092103001041000_105.10.981.6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0960327116658108","article-title":"Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: a prospective study in 154 children","volume":"36","author":"Ustyol","year":"2017","journal-title":"Hum Exp Toxicol"},{"key":"2024092103001041000_105.10.981.7","doi-asserted-by":"crossref","DOI":"10.4081\/pr.2012.e14","article-title":"Urinary sludge caused by ceftriaxone in a young boy","volume":"4","author":"Kimata","year":"2012","journal-title":"Pediatr Rep"},{"key":"2024092103001041000_105.10.981.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016273"},{"key":"2024092103001041000_105.10.981.9","unstructured":"Higgins J , Green S . Cochrane Handbook for systematic reviews of interventions. Chichester, UK: The Cochrane Library, John Wiley & Sons, 2011."},{"key":"2024092103001041000_105.10.981.10","unstructured":"Wells GA , Shea B , O\u2019 Connell D , et al . The Newcastle-Ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses Availabel at. Available: http:\/\/www. ohri. ca\/ programs\/clinical_epidemiology\/oxford. htm"},{"key":"2024092103001041000_105.10.981.11","unstructured":"Review Manager (RevMan) [Computer program] . Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014."},{"key":"2024092103001041000_105.10.981.12","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2018-102911"},{"key":"2024092103001041000_105.10.981.13","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001159"},{"key":"2024092103001041000_105.10.981.14","first-page":"390","article-title":"The comparison of single-dose ceftriaxone, Five-day azithromycin, and ten-day amoxicillin\/clavulanate for the treatment of children with acute otitis media","volume":"49","author":"Biner","year":"2007","journal-title":"Turk J Pediatr"},{"key":"2024092103001041000_105.10.981.15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.14740\/jocmr2523w","article-title":"Antibiotics for post-tonsillectomy morbidity: comparative analysis of a single institutional experience","volume":"8","author":"Aljfout","year":"2016","journal-title":"J Clin Med Res"},{"key":"2024092103001041000_105.10.981.16","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200011000-00006"},{"key":"2024092103001041000_105.10.981.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.08.005"},{"key":"2024092103001041000_105.10.981.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70417-5"},{"key":"2024092103001041000_105.10.981.19","first-page":"216","article-title":"[Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases]","volume":"48","author":"Zhong","year":"2010","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2024092103001041000_105.10.981.20","first-page":"404","article-title":"Billary precipitation during ceftriaxone therapy: frequency and risk factors","volume":"49","author":"Soyal","year":"2007","journal-title":"Turkish J Pediatr"},{"key":"2024092103001041000_105.10.981.21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G"},{"key":"2024092103001041000_105.10.981.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0401-2"},{"key":"2024092103001041000_105.10.981.23","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014548310"},{"key":"2024092103001041000_105.10.981.24","first-page":"1","article-title":"Risk of invasive pneumococcal disease in children with sickle cell disease in England: a national observational cohort study 2010\u20132015","volume":"0","author":"Oligbu","year":"2017","journal-title":"BMJ"},{"key":"2024092103001041000_105.10.981.25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2182"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2019-317950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T10:02:18Z","timestamp":1726912938000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2019-317950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,18]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/archdischild-2019-317950"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2019-317950","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]}}}